Pieris Pharmaceuticals Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 25 institutions reported holding Pieris Pharmaceuticals Inc. in their 13F filings, up 5 from Q2 2024. 7 opened new positions and 2 sold out. The largest holders were BVF Inc. ($4.3M), ADAR1 Capital Management, LLC ($2.4M) and BML Capital Management, LLC ($699K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Pieris Pharmaceuticals Inc.
- CUSIP
- 720795202
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $3.9M |
| Exits | 2 | $3K |
All 13F filers, Q2 2024 → Q3 2024: 258,982 shares bought and 15,625 shares sold, net +243,357 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| BVF Inc. | 0.13% | No change | 257,626 | $4.3M |
| ADAR1 Capital Management, LLC | 0.40% | New | 144,641 | $2.4M |
| BML Capital Management, LLC | 0.41% | New | 42,130 | $699K |
| Lynx1 Capital Management LP | 0.22% | Reduce -13.9% | 37,436 | $621K |
| Renaissance Technologies | 0.00% | Add +180.5% | 32,171 | $533K |
| CM Management, LLC | 0.30% | New | 22,500 | $373K |
| Frazier Life Sciences Management, L.P. | 0.01% | New | 15,942 | $267K |
| BlackRock, Inc. | 0.00% | — | 12,938 | $215K |
| Geode Capital Management, LLC | 0.00% | Add +12.8% | 11,981 | $201K |
| Citadel Advisors | 0.00% | New | 11,686 | $196K |
| Vanguard Group Inc. | 0.00% | No change | 11,342 | $190K |
| Acadian Asset Management LLC | 0.00% | Reduce -72.2% | 3,013 | $49K |
| Citigroup Inc. | 0.00% | No change | 1,108 | $19K |
| UBS Group AG | 0.00% | Reduce -79.8% | 348 | $6K |
| Group One Trading LLC | 0.00% | Reduce -3.4% | 312 | $5K |
| US Bancorp \de | 0.00% | Reduce -12.7% | 138 | $2K |
| Morgan Stanley | 0.00% | Add +11.0% | 91 | $2K |
| Barclays PLC | 0.00% | No change | 63 | $1K |
| Wells Fargo & Company | 0.00% | No change | 60 | $995 |
| JPMorgan Chase & Co. | 0.00% | Reduce -3.7% | 26 | $435 |
| Truvestments Capital LLC | 0.00% | New | 14 | $232 |
| Bank of America Corp. | 0.00% | No change | 13 | $215 |
| Osaic Holdings, Inc. | 0.00% | No change | 7 | $116 |
| Allworth Financial LP | 0.00% | No change | 5 | $83 |
| Danske Bank A/S | 0.00% | New | 2 | $33 |
"% of holder's portfolio" is PIERIS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Pieris Pharmaceuticals Inc. the manager owns.